EGF and lung cancer: For instance, mutant p53 (p53-273H) suppresses miR-27a expression by specifically binding to the miR-27a promoter region (nts -2899 to -2675) and subsequently enhances EGF-mediated ERK1/2 activation in breast and lung cancer cells [38].